"study","treatment","responders","sampleSize"
"ARISTOTLE","Apixaban_5_mg",603,9120
"ARISTOTLE","Warfarin",669,9081
"ARISTOTLE-J","Apixaban_5_mg",0,74
"ARISTOTLE-J","Warfarin",0,74
"ENGAGE AF-TIMI","Edoxaban_30_mg",737,7034
"ENGAGE AF-TIMI","Edoxaban_60_mg",773,7035
"ENGAGE AF-TIMI","Warfarin",839,7036
"J-ROCKET","Rivaroxaban_15_mg",7,637
"J-ROCKET","Warfarin",5,637
"RE-LY","Dabigatran_110_mg",446,6015
"RE-LY","Dabigatran_150_mg",438,6076
"RE-LY","Warfarin",487,6022
"ROCKET-AF","Rivaroxaban_20_mg",208,7061
"ROCKET-AF","Warfarin",250,7062
"Yamashita, 2012","Edoxaban_30_mg",0,131
"Yamashita, 2012","Edoxaban_60_mg",1,131
"Yamashita, 2012","Warfarin",1,129
